SG10201406288SA - Multimeric forms of antimicrobial peptides - Google Patents
Multimeric forms of antimicrobial peptidesInfo
- Publication number
- SG10201406288SA SG10201406288SA SG10201406288SA SG10201406288SA SG10201406288SA SG 10201406288S A SG10201406288S A SG 10201406288SA SG 10201406288S A SG10201406288S A SG 10201406288SA SG 10201406288S A SG10201406288S A SG 10201406288SA SG 10201406288S A SG10201406288S A SG 10201406288SA
- Authority
- SG
- Singapore
- Prior art keywords
- peptides
- multimeric forms
- antimicrobial
- defensin
- antimicrobial peptides
- Prior art date
Links
- 102000044503 Antimicrobial Peptides Human genes 0.000 title abstract 3
- 108700042778 Antimicrobial Peptides Proteins 0.000 title abstract 3
- 102000000541 Defensins Human genes 0.000 abstract 4
- 108010002069 Defensins Proteins 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 230000000845 anti-microbial effect Effects 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000000882 contact lens solution Substances 0.000 abstract 1
- 239000003889 eye drop Substances 0.000 abstract 1
- -1 for example Proteins 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Eyeglasses (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4658408P | 2008-04-21 | 2008-04-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201406288SA true SG10201406288SA (en) | 2014-12-30 |
Family
ID=41217076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201406288SA SG10201406288SA (en) | 2008-04-21 | 2009-04-21 | Multimeric forms of antimicrobial peptides |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8809262B2 (enExample) |
| EP (2) | EP2853539B1 (enExample) |
| JP (2) | JP5753077B2 (enExample) |
| AU (1) | AU2009238701B2 (enExample) |
| BR (1) | BRPI0910473A2 (enExample) |
| SG (1) | SG10201406288SA (enExample) |
| WO (1) | WO2009131548A1 (enExample) |
| ZA (1) | ZA201007509B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009535027A (ja) * | 2006-04-27 | 2009-10-01 | シンガポール ヘルス サービシーズ ピーティーイー リミテッド | 抗菌ペプチド |
| US20110311601A1 (en) * | 2010-06-22 | 2011-12-22 | Michael Kleine | Antimicrobial medical devices |
| CN102260321A (zh) * | 2011-04-02 | 2011-11-30 | 新加坡保健服务集团 | 抗菌肽的多聚体形式 |
| EP2892913A4 (en) * | 2012-09-07 | 2017-01-18 | Agency For Science, Technology And Research | Peptides and their uses |
| EP2892914B1 (en) * | 2012-09-07 | 2018-05-23 | Agency For Science, Technology And Research | Tetrabranched peptides and analogues as a new class of antimicrobials and their preparation thereof |
| JP6362878B2 (ja) * | 2013-03-12 | 2018-07-25 | 国立研究開発法人農業・食品産業技術総合研究機構 | 改変ペプチド繰り返しペプチドを含む融合タンパク質および該融合タンパク質を含むシルク繊維 |
| WO2015138494A1 (en) | 2014-03-10 | 2015-09-17 | Georges Belfort | Anti-microbial peptides and method for designing novel anti-microbial peptides |
| WO2016081594A1 (en) * | 2014-11-19 | 2016-05-26 | The General Hospital Corporation | System and method for photo-dynamic procedure |
| EP3303376A4 (en) * | 2015-05-29 | 2019-01-23 | Hexima Limited | IN VIVO METHOD |
| EP3392263A4 (en) * | 2015-12-14 | 2020-03-04 | Su Han | POLYPEPTIDE COMPOUND, METHOD FOR PREPARING THE SAME, AND USE THEREOF |
| US20220133699A1 (en) | 2019-02-14 | 2022-05-05 | Singapore Eye Research Institute | Antibacterial Compositions |
| EP4232460A4 (en) * | 2020-10-22 | 2024-10-09 | The University of Hong Kong | COMPOSITIONS OF ANTIVIRAL PEPTIDES AND/OR COMPOUNDS AND METHODS OF USE THEREOF |
| US20240197823A1 (en) * | 2021-02-12 | 2024-06-20 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cationic antimicrobial peptides and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5057520A (en) * | 1989-03-24 | 1991-10-15 | Abbott Laboratories | 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds |
| US5639594A (en) * | 1990-02-16 | 1997-06-17 | United Biomedical, Inc. | Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis |
| US5919761A (en) * | 1992-08-14 | 1999-07-06 | The Board Of Regents Of The University Of Michigan | Peptides for heparin and low molecular weight heparin anticoagulation reversal |
| US8172395B2 (en) * | 2002-12-03 | 2012-05-08 | Novartis Ag | Medical devices having antimicrobial coatings thereon |
| GB0514482D0 (en) * | 2005-07-14 | 2005-08-17 | Ares Trading Sa | Protein |
| US20070053934A1 (en) | 2005-08-26 | 2007-03-08 | Neville Kallenbach | Polyvalent multimeric composition containing active polypeptides, pharmaceutical compositions and methods of using the same |
| US7531505B2 (en) * | 2006-01-11 | 2009-05-12 | Affinergy, Inc. | Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices |
| JP2009535027A (ja) * | 2006-04-27 | 2009-10-01 | シンガポール ヘルス サービシーズ ピーティーイー リミテッド | 抗菌ペプチド |
-
2009
- 2009-04-21 EP EP14190318.7A patent/EP2853539B1/en not_active Not-in-force
- 2009-04-21 WO PCT/SG2009/000144 patent/WO2009131548A1/en not_active Ceased
- 2009-04-21 BR BRPI0910473A patent/BRPI0910473A2/pt not_active IP Right Cessation
- 2009-04-21 JP JP2011506235A patent/JP5753077B2/ja not_active Expired - Fee Related
- 2009-04-21 SG SG10201406288SA patent/SG10201406288SA/en unknown
- 2009-04-21 AU AU2009238701A patent/AU2009238701B2/en not_active Ceased
- 2009-04-21 EP EP09734345.3A patent/EP2279202B1/en not_active Not-in-force
- 2009-04-21 US US12/988,994 patent/US8809262B2/en not_active Expired - Fee Related
-
2010
- 2010-10-21 ZA ZA2010/07509A patent/ZA201007509B/en unknown
-
2015
- 2015-02-20 JP JP2015031712A patent/JP2015145373A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201007509B (en) | 2013-06-26 |
| JP5753077B2 (ja) | 2015-07-22 |
| AU2009238701A1 (en) | 2009-10-29 |
| JP2015145373A (ja) | 2015-08-13 |
| WO2009131548A1 (en) | 2009-10-29 |
| US8809262B2 (en) | 2014-08-19 |
| EP2279202B1 (en) | 2015-08-12 |
| EP2853539B1 (en) | 2018-10-10 |
| EP2853539A1 (en) | 2015-04-01 |
| BRPI0910473A2 (pt) | 2019-09-24 |
| EP2279202A1 (en) | 2011-02-02 |
| AU2009238701B2 (en) | 2013-06-20 |
| US20110039760A1 (en) | 2011-02-17 |
| WO2009131548A8 (en) | 2010-11-25 |
| EP2279202A4 (en) | 2011-08-31 |
| JP2011521902A (ja) | 2011-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009131548A8 (en) | Multimeric forms of antimicrobial peptides | |
| MX2009000285A (es) | Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas. | |
| MX2009011276A (es) | Inhibidor de dpp-iv que incluye el grupo beta-amino, metodo para la preparacion del mismo y composicion farmaceutica que contiene el mismo para prevenir y tratar una diabetes o una obesidad. | |
| EP2494059A4 (en) | USE OF METHYLSULFONYLMETHANE (MSM) TO MODULATE MICROBIAL ACTIVITY | |
| CA2747703C (en) | Compositions and methods for the treatment or the prevention of infections by e. coli | |
| EA201290837A1 (ru) | Лечение волчаночного нефрита с применением лаквинимода | |
| MY148844A (en) | Fumarate salt of (alpha s, beta r)-6- bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol | |
| UA109878C2 (uk) | Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти) | |
| PH12013500152A1 (en) | New aminopyrazoloquinazolines | |
| ZA200809250B (en) | Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors | |
| NZ610315A (en) | Antiviral condensed heterocyclic compounds | |
| MX355153B (es) | Combinaciones de compuestos activos que comprenden derivados de carboxamida y un agente de control biologico. | |
| MX2011012643A (es) | 2,4-diaminopiridinas para el tratamiento de enfermedades caracterizadas por la proliferacion celular excesiva o anormal. | |
| MX2009007345A (es) | Compuestos con (fenil sustituido), con restos de propenal, sus derivados, actividad biologica y uso del mismo. | |
| MX2009008542A (es) | Agentes de suministro de acido fenilalquilcarboxilico. | |
| NZ596313A (en) | Pharmaceutical compositions containing antifungal peptides | |
| GB201001602D0 (en) | Oligopeptidic compounds and uses therof | |
| MX2012000136A (es) | Composiciones que comprenden finafloxacina y metodos para tratar infecciones oftalmicas, oticas, o nasales. | |
| GB0404374D0 (en) | Treatment of bacterial infections | |
| GEP201606514B (en) | Apoptosis inhibitors and usage thereof | |
| DE602007011975D1 (de) | Thiadiazolderivate zur behandlung neurodegenerativer krankheiten | |
| AU2011279845A8 (en) | Novel pyrrolidine derived beta 3 adrenergic receptor agonists | |
| MX2010008490A (es) | Triazolopiridazinas como inhibidores de par1, su produccion y su uso como medicamentos. | |
| CL2013000331A1 (es) | Compuestos derivados de triazina-1,2 diazol condezada o de triazina-1,2,4-triazol condensada; proceso para preparar estos compuestos; composicion farmaceutica; proceso para preparar esta composicion farmaceutica; y su uso para el tratamiento de una infeccion bacteriana tal como una infeccion por la bacteria clostridium. | |
| MX2015008373A (es) | Peptidos antimicrobianos, composiciones que los comprende y usos. |